Cargando…

Biological Function and Application of Picornaviral 2B Protein: A New Target for Antiviral Drug Development

Picornaviruses are associated with acute and chronic diseases. The clinical manifestations of infections are often mild, but infections may also lead to respiratory symptoms, gastroenteritis, myocarditis, meningitis, hepatitis, and poliomyelitis, with serious impacts on human health and economic los...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zengbin, Zou, Zixiao, Jiang, Zeju, Huang, Xiaotian, Liu, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630369/ https://www.ncbi.nlm.nih.gov/pubmed/31167361 http://dx.doi.org/10.3390/v11060510

Ejemplares similares

The 5′-Untranslated Region of Picornaviral Genomes
por: Agol, Vadim I.
Publicado: (1991)

Efficacy and Safety of Oncolytic Viruses in Randomized Controlled Trials: A Systematic Review and Meta-Analysis
por: Li, Zengbin, et al.
Publicado: (2020)

A picornaviral loop-to-loop replication complex
por: Claridge, Jolyon K., et al.
Publicado: (2009)

Novel Roles of the Picornaviral 3D Polymerase in Viral Pathogenesis
por: Kerkvliet, Jason, et al.
Publicado: (2010)

MicroRNA Antagonism of the Picornaviral Life Cycle: Alternative Mechanisms of Interference
por: Kelly, Elizabeth J., et al.
Publicado: (2010)

Structures and Corresponding Functions of Five Types of Picornaviral 2A Proteins
por: Yang, Xiaoyao, et al.
Publicado: (2017)

Roles of the Picornaviral 3C Proteinase in the Viral Life Cycle and Host Cells
por: Sun, Di, et al.
Publicado: (2016)

Hijacking of multiple phospholipid biosynthetic pathways and induction of membrane biogenesis by a picornaviral 3CD protein
por: Banerjee, Sravani, et al.
Publicado: (2018)

A conserved RNA structural motif for organizing topology within picornaviral internal ribosome entry sites
por: Koirala, Deepak, et al.
Publicado: (2019)

NMR analysis of the interaction of picornaviral proteinases Lb and 2A with their substrate eukaryotic initiation factor 4GII
por: Aumayr, Martina, et al.
Publicado: (2015)

Recent highlights in the development of new antiviral drugs
por: De Clercq, Erik
Publicado: (2005)

Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development
por: Wan, Qianya, et al.
Publicado: (2020)

Structural biology in antiviral drug discovery
por: Bassetto, Marcella, et al.
Publicado: (2016)

Druggable targets from coronaviruses for designing new antiviral drugs
por: Silva, Leandro Rocha, et al.
Publicado: (2020)

Development and Effects of Influenza Antiviral Drugs
por: Yin, Hang, et al.
Publicado: (2021)

Approaches to antiviral drug development.
por: Prusoff, W. H., et al.
Publicado: (1989)

Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
por: Xiang, Qi, et al.
Publicado: (2022)

The host interactome of influenza virus presents new potential targets for antiviral drugs
por: Shaw, Megan L.
Publicado: (2011)

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
por: Spratt, Austin N., et al.
Publicado: (2021)

Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies
por: Emonet, Sebastien E., et al.
Publicado: (2011)

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis
por: Cheng, Feixiong, et al.
Publicado: (2016)

Norovirus: Targets and tools in antiviral drug discovery
por: Rocha-Pereira, Joana, et al.
Publicado: (2014)

Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents
por: Dinman, Jonathan D, et al.
Publicado: (1998)

Thiazolides: A New Class of Broad-Spectrum Antiviral Drugs Targeting Virus Maturation
por: Santoro, M. Gabriella, et al.
Publicado: (2007)

Dengue virus NS4B protein as a target for developing antivirals
por: Li, Qingxin, et al.
Publicado: (2022)

In vitro assay by bioengineering of new antiviral drugs
por: Tashuta, Viktor, et al.
Publicado: (2014)

Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition
por: Sanna, Vanna, et al.
Publicado: (2022)

The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B
por: Tang, Hong, et al.
Publicado: (2013)

Cell-Penetrating Peptides for Antiviral Drug Development
por: Delcroix, Melaine, et al.
Publicado: (2010)

Antiviral drugs specific for coronaviruses in preclinical development
por: Adedeji, Adeyemi O, et al.
Publicado: (2014)

Ethnomedicinal Wisdom: An Approach for Antiviral Drug Development
por: Mahapatra, Ananya Das, et al.
Publicado: (2019)

Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues
por: Acquavia, Maria A., et al.
Publicado: (2021)

Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers
por: Cojocaru, Florina-Daniela, et al.
Publicado: (2020)

Dominant drug targets suppress the emergence of antiviral resistance
por: Tanner, Elizabeth J, et al.
Publicado: (2014)

Coronavirus main proteinase: target for antiviral drug therapy
por: Anand, Kanchan, et al.
Publicado: (2005)

Host-targeting oral antiviral drugs to prevent pandemics
por: Dwek, Raymond A, et al.
Publicado: (2022)

Plasticity of the 340-Loop in Influenza Neuraminidase Offers New Insight for Antiviral Drug Development
por: Han, Nanyu, et al.
Publicado: (2020)

Editorial overview: Antiviral strategies: Antiviral drug development for single-stranded RNA viruses
por: Brinton, Margo A, et al.
Publicado: (2019)

Advances in new antivirals for chronic hepatitis B
por: Tang, Yanhua, et al.
Publicado: (2022)

Antiviral Drugs
por: Vardanyan, Ruben, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7dvfuolh02lrtp4965h9uhegov